www.fdanews.com/articles/137904-watson-invests-44m-to-triple-capacity-for-transdermal-patch-and-topical-gel-manufacture

Watson Invests $44M to Triple Capacity for Transdermal Patch and Topical Gel Manufacture

June 24, 2011

Watson Pharmaceuticals will invest about $44 million into the expansion of its Watson Laboratories site in Salt Lake City, which operates as the firm’s pharmaceutical research, development, and manufacturing facility for transdermal patches and topical gels.
Genetic Engineering and Biotechnology News